A randomised open label study on potential effects of Ayurveda in schizophrenia
- Conditions
- Health Condition 1: F20- Schizophrenia
- Registration Number
- CTRI/2023/08/056921
- Lead Sponsor
- DrAkhila Soman
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Diagnosed patients of Unmada according to Ayurveda and patients of Schizophrenia as per DSM-5-TR
Patients with predominant Negative symptoms (Any of the 4 Global scores of
Scale for the Assessment of Negative Symptoms- SANS= 3).
Mild or lesser level of positive symptoms (Global score of all items of Scale for
the Assessment of Positive Symptoms SAPS < 3)
Patients who are in the capacity to provide informed consent (as assessed by
UBACC- University of California, San Diego Brief Assessment of Capacity to
Consent (UBACC) will be recruited. Those who do not have the capacity, caregiver’s consent will be
taken.
Patients who are on stable medications for atleast 1 month.
Patients with bipolar affective disorder, substance use disorders (except
nicotine and caffeine), major systemic illness, neurological disorders and
immune system disorders.
Patients with suicidal tendencies.
Patients scoring > 7 in Hamilton Depression Rating Scale.
Pregnant and lactating mothers.
Patients unsuitable for Vamana procedure – heart diseases, severe hepatic,
renal or pulmonary dysfunction.
Patients who have undergone Vamana or Virechana karma in the last 3
months.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method